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Crystal Structure at 2.4 A˚ Resolution
of the Complex of Transducin bg
and Its Regulator, Phosducin
Rachelle Gaudet, Andrew Bohm, and Paul B. Sigler Gtbg with high affinity, sequestering Gtbg and translocat-
ing Gtbg away from the disk membrane (Lee et al., 1988).Department of Molecular Biophysics and Biochemistry
Howard Hughes Medical Institute This translocation and sequestration is thought to pre-
vent the reassociationof Gtbg with Gta, thereby reducingYale University
New Haven, Connecticut 06511 signal amplification at the G protein level. In dark-
adapted rods, phosducin is phosphorylated at serine 73
by protein kinase A (PKA) (Lee et al., 1990a). Phosphory-
lation of phosducin reduces the stability of the phos-Summary
ducin/Gtbg complex (Yoshida et al., 1994), allowing Gta
to reassociate promptly with Gtbg and maximizing theThe crystal structure of transducin’s bg subunits com-
photon signal amplification. Phosducin is dephosphory-plexed with phosducin, which regulates Gtbg activity,
lated by type 1 or 2A phosphatases (Pagh-Roehl et al.,has been solved to 2.4 A˚ resolution. Phosducin has two
1995).domains that wrap around Gtbg to form an extensive
It is likely that phosducin plays a role in signal trans-interface. The N-terminal domain binds loops on the
duction in a variety of tissues. Phosducin is present at“top” Gtb surface, overlapping the Gta binding surface,
high levels in the pineal gland, an organ developmentallyexplaining how phosducin blocks Gtbg’s interaction
and functionally related to the retina (Reig et al., 1990).with Gta. The C-terminal domain shows structural ho-
Phosducin has also been purified from brain (Bauer etmology to thioredoxin and binds the outer strands of
al., 1992), and mRNA and protein expression have beenGtb’s seventh and first blades in a manner likely to
detected in other tissues (Bauer et al., 1992; Danner anddisrupt Gtbg’s normal orientation relative to the mem-
Lohse, 1996). Phosducin is extremely well conserved inbrane and receptor. Phosducin’s Ser-73, which when
mammals (see Figure 1) and is also found in teleostsphosphorylated inhibits phosducin’s function, points
(Pagh-Roehl et al., 1995). A putative homolog has alsoaway from Gtbg, toward a large flexible loop. Thus
been sequenced from yeast (GenBank accession num-phosphorylation is not likely to affect the interface
ber Z46727) and shown to bind yeast Gbg (P. DiBellodirectly, but rather indirectly through an induced con-
and H. Dohlman, personal communication). Further-formational change.
more, phosducin-like proteins (PhlPs) have been cloned
from mouse and rat using a screen for mRNAs with
Introduction an alcohol-induced increase in expression (Miles et al.,
1993). These PhlPs have a broad tissue distribution and
Heterotrimeric Gproteins are intracellular transducers of are also apparent Gbg regulators (Schro¨der and Lohse,
numerous extracellular signals sensed by seven-helical 1996). Although mutations in phosducin have not yet
transmembrane (7TM) receptors. One of the best char- been shown to directly cause disease, the human phos-
acterized heterotrimeric G protein-coupled pathways is ducin gene has been mapped to the region of linkage
the rod cell visual signal transduction system (reviewed of several retinopathies (Mansergh et al., 1994).
in Lolley and Lee, 1990; Hargrave and McDowell, 1992), Here we present the crystal structure of the phos-
where rhodopsin receives photons through its retinal ducin/Gtbg complex solved by a double-edge multiple
chromophore and activates the G protein transducin by wavelength anomalous diffraction (MAD) experiment
catalyzing nucleotide exchange. GTP-bound transducin and refined to2.4 A˚ resolution. We describe thestructure
a (Gta•GTP) dissociates from Gtbg and goes on to acti- of phosducin and its interactions with Gtbg and discuss
vate cGMP phosphodiesterase. The resulting decrease the way in which phosducin and phosducin-like proteins
in cGMP causes cGMP-gated cation channels to close, may regulate Gbg interactions with Ga and with Gbg
leading to cellular hyperpolarization. In a dark-adapted effector molecules.
rod cell, the action of one photon is sufficient to activate
one rhodopsin molecule and lead to the degradation of
more than 100,000 cGMP molecules, enough to cause Results and Discussion
a neural impulse. This remarkable level of amplification
is clearly too high for daytime vision. It is known that rod Structure Determination and Refinement
N-terminally His-tagged selenomethionine-substitutedcells undergo light-adaptation and that the metabolism,
gene expression, and membrane renewal of rods rat phosducin was expressed and purified as detailed
in Experimental Procedures. Phosducin was complexedchange from dark to light. Rhodopsin kinase and ar-
restin, which shut off rhodopsin, are involved in the with endoproteinase-LysC proteolysed bovine Gtbg and
crystallized by vapor diffusion. This proteolysis of Gtbgrapid,short-term down-regulationof thepathway. Phos-
ducin has been proposed to play an important role in removes the last three residues in the g subunit including
the attached farnesyl moiety. The crystals are of spacelong-term light-adaptation of rod cells (Wilkins et al.,
1996). group P212121 and contain one phosducin/Gtbg complex
per asymmetric unit. The structure of the phosducin/Phosducin is expressed at high levels in retinal rods,
where the amount of phosducin is similar to the amount Gtbg complex was solved using data collected at three
wavelengths around the selenium Kb1 edge and oneof transducin (Lee et al., 1990b, Wilkins et al., 1996). In
light-adapted rods, unphosphorylated phosducin binds wavelength at the gadolinium Lg1 edge. Tables 1 and 2
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Figure 1. Sequence and Secondary Structure Features of Phosducin and Gtb
The top panel shows the amino acid sequence alignment of two phosducins (rat and bovine), PhlP (rat long form, EMBL accession number
L15355), the putative yeast homolog of phosducin (GenBank accession number Z46727), and thioredoxin (E. coli). SWISSPROT accession
numbers are, from top to bottom, P20942, P19632, NA, NA, P00274. The three other available phosducin sequences (human, cat, mouse)
were omitted as they are highly homologous to the rat and bovine sequences, with their Gtbg interacting residues identical to the rat sequence.
Residues that contact Gtb are highlighted in blue. The blue arrow marks the start of the PlhP short form while black arrows indicate exon
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Table 1. Summary of Data Collection Statistics
Dataset Resolution Rsyma (%) % Coverage
(Wavelength in A˚) Df9/Df99 Se Df9/Df99 Gd Limit (A˚) [Last Shell] [Last Shell]
l1 5 0.9840 24.96/0.50 20.91/6.70 2.6 5.7 [21.6] 98.6 [97.4]
l2 5 0.9794 ,29/2.17c 20.91/6.70 2.6 4.8 [19.8]b 98.3 [96.6]
l3 5 0.9791 ,27/5.33c 20.91/6.70 2.6 4.8 [21.2]b 97.8 [94.8]
l1–2 5 0.9840 24.96/0.50 20.91/6.70 2.4 6.0 [30.1] 94.9 [96.8]
l4 5 1.7109 20.70/1.40 ,219/.10 3.5 10.9 [30.0]b 85.1 [83.6]
a Rsym 5 S|Ih2,Ih.|/SIh where ,Ih. is the average over Friedel and symmetry equivalents.
b Friedel pairs were not merged.
c Estimated from fluorescence spectra. Other values estimated using method of Cromer and Liberman (1981).
summarize the data collection and phasing statistics. and formsan extensive interactionsurface with the“top”
of the Gtbg propeller, the same Gtbg face that interactsSolvent-flattened experimental electron-density maps
were used to trace most of the phosducin chain, and with Gta’s switch 2 region (Lambright et al., 1996). The
N-terminal domain of phosducin appears to be very flex-the selenium sites helped to ensure the correctness
of the sequence registration. Gtbg was placed in the ible especially in the regions where it does not contact
Gtbg, with an average B factor of z41 A˚2 compared toelectron density by conventional molecular replace-
ment. The model was refined to 2.4 A˚ resolution using z21 A˚2 for Gtbg and the rest of phosducin. The high
hydrophilicity of the N-terminal 105 residues (Hawes eta combination of positional refinement, simulated an-
nealing, and cycles of manual fitting and rebuilding. Low al., 1994) might explain why this domain does not fold
tightly. Helix 1 forms the core of the N-terminal domainresolution data to 50 A˚ was included in the refinement
using a flat bulk solvent correction (Jiang and Bru¨nger, and contains the functionally important residue Trp-29
(Xu et al., 1995). Helix 1 is surrounded on all sides by1994). The current model includes residues 14–36 and
67–230 of phosducin, residues 1–340 of Gtb, residues the remainder of the N-terminal domain. A 30 amino
acid segment from Asp-37 to Arg-66 is disordered in the1–68 of Gtg, 257 water molecules, and 5 Gd31 ions. The
structure has an R factor of 19.2% (data > 2s) and a structure, showing weak electron density, presumably
because of inherent flexibility. The backbone of this re-free R factor of 27.6% (data > 2s). An example of the
sA-weighted 2Fo-Fc map (Read, 1986) is shown in Figure gion has been tentatively traced and is colored white in
Figure 4A and green in Figure 6. From the available2. Table 3 summarizes the refinement statistics. All
backbone torsion angles lie in allowed regions of the trace, the position of the adjoining residues and crystal
packing constraints, it is likely that this disordered re-Ramachandran plot and the root mean squared devia-
tion in bond lengths and angles are 0.009 A˚ and 1.5, gion passes close to phosducin’s PKA phosphorylation
site, Ser-73, whose side chain is pointed toward thisrespectively.
segment (see Figure 6). This immediately suggests that:
(a) the phosphorylation site is accessible to PKA andPhosducin Structure
Phosducin is composed of two domains, as shown in phosphatase, and (b) the presence of the phosphate
may impose structure upon an otherwise disorderedFigures 3 and 4. The N-terminal domain is mostly helical
Table 2. Phasing Statistics
Resolution (A˚) 9.40 6.84 5.38 4.43 3.77 3.28 2.90 2.60 Overall
Phasing Powera
Isomorphous (l2) 0.47 0.62 0.83 0.67 0.48 0.42 0.32 0.23 0.41
Anomalous (l2) 0.99 1.29 1.36 1.22 1.09 0.93 0.70 0.47 0.84
Isomorphous (l3) 0.31 0.56 0.58 0.43 0.30 0.29 0.22 0.15 0.28
Anomalous (l3) 0.84 1.07 1.21 1.13 1.02 0.88 0.66 0.44 0.79
Isomorphous (l4) 0.41 0.61 0.52 0.35 0.34 0.30 — — 0.38
Anomalous (l4) 0.85 1.06 1.01 0.90 0.70 0.58 — — 0.80
Mean figure of merit 0.61 0.63 0.66 0.56 0.50 0.40 0.30 0.19 0.39
a Isomorphous phasing power 5 S|FH|/S||FPHobs|2|FPHcalc||; anomalous phasing power 5 S|F99H|/S||ADobs|2|ADcalc||.
breaks in phosducin genes. Serine 73, the PKA phosphorylation site on phosducin, is marked by a red arrow. A dotted line in the secondary
structure diagram indicates parts of the protein that have uninterpretable or questionable electron density. The bottom panel shows the
alignment of 11 Gb subunits. Residues that contact phosducin are highlighted in blue. Red-starred residues interact with Ga. SWISSPROT
accession numbers are, from top to bottom, P04901, P11016, P16520, P29387, NA, P17343, P23232, P26308, P36408, P29829, P18851, where
NA indicates not available and EMBL accession number L34290. Genetics Computer Group Wisconsin package v. 8 was used for initial
alignments, which were then subjectively modified based on the observed secondary structure. Specific interactions are those less than 3.6
A˚ apart and were visually inspected for reasonable stereochemistry. Contacts are residues that either bury >20% of their solvent-accessible
surface area or make specific interactions. Secondary structure and solvent-accessible surface area are based on DSSP (Kabsch and Sander,
1983).
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Figure 2. Representative Electron Density
sA-weighted 2Fo-Fc electron-density map contoured at 2s showing residues at Gtbg’s interface with phosducin’s C-terminal domain. Gtbg is
white and phosducin yellow. Gd denotes a bound gadolinium ion. This figure was generated in O (Jones et al., 1991).
region (see below). Although it has been postulated that 112–218 of the C-terminal domain of phosducin (Figure
4B) the corresponding Ca atoms deviate by a root meanthe N-terminal sequence of phosducin might contain
part of a pleckstrin-homology domain (Hawes et al., squared distance (RMSD) of 3.1 A˚. If the comparison is
restricted to the secondary structure, the deviation is1994), the phosducin crystal structure shows no similar-
ity to known PH domain structures (reviewed in Lemmon reduced to 1.6 A˚. As in thioredoxin, the phosducin
C-terminal domain contains a fifth strand and an extraet al., 1996).
The C-terminal domain of phosducin is a five-stranded a helix N-terminal to the thioredoxin fold (Martin, 1995).
However, it appears that this similarity is playing a purelymixed b sheet with a helices packing against both sides.
It belongs to the family of proteins containing the“thiore- structural role as phosducin contains only one of the
two conserved cysteines that are characteristic of thedoxin fold” (see Figure 3). The thioredoxin fold (shaded
gray in Figure 3) consists of a four-stranded b sheet and thioredoxin active site disulfide bridge.
three flanking a helices and is present in five classes of
proteins, all interacting with cysteine-containing sub- Gtbg Structure and Conformational Changes
As described previously (Lambright et al., 1996; Sondekstrates (Martin, 1995). The C-terminal domain of phos-
ducin is clearly closer to thioredoxin than to any of the et al., 1996) and illustrated in Figure 5A, Gtb has a long
N-terminal helix followed by a seven-bladed b propeller,other thioredoxin-fold protein classes, and in fact, it has
weak sequence homology to thioredoxin (22% identity each blade consisting of a four-stranded antiparallel b
sheet. The seven-fold repeat in the structure of Gtb isand 52% similarity). When the structure of E. coli thiore-
doxin (Katti et al., 1990) is superimposed onto residues mirrored by a sequence repeat, the “WD40 motif” (Neer
Table 3. Refinement Statistics
Resolution (A˚) R Factor Free R Factora No. Reflections
Data with F . 2s 50.0–2.4 19.2 27.6 24085
All data 50.0–2.4 20.9 28.8 25859
rms deviations
bond lengths: 0.009 A˚
bond angles: 1.5248
improper dihedrals: 1.3178
a 10% of the data.
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two sets of previous reports: one stating that the
N-terminal domain of phosducin is important for Gtbg
binding (Hawes et al., 1994; Xu et al., 1995) and the
second showing that the short form of phosducin-like
protein, which lacks most of the N-terminal domain, still
binds Gbg (Figure 1) (Schro¨der and Lohse, 1996). The
short form of PhlP binds Gtbg with 5-fold lower affinity
than phosducin (Schro¨der and Lohse, 1996). The long
form of PhlP is likely to bind Gtbg with an affinity compa-
rable to phosducin since it retains its N-terminus, includ-
ing a highly conserved 11-residue stretch important for
Gtbg binding, as discussed below.
Phosducin’s tryptophan 29 has been mutationally im-
plicated in Gtbg binding (Xu et al., 1995) and appears,
from the structure, to play an important role in the stabil-
ity of the N-terminal domain. In addition to contacting
two Gtb residues (bTrp-99 and bLeu-117), phosducin’s
Trp-29 interacts with several phosducin residues form-
ing a small hydrophobic core in the otherwise loosely
structured N-terminal domain. Furthermore, Trp-29 is
part of a segment of 11 contiguous amino acids, 20-
TGPKGVINDWR-30, that is absolutely conserved in
phosducin and is also present in PhlP-long (see the
sequence alignment in Figure 1). This region, which lies
at the N-terminal end of helix 1, caps the cylindrical hole
Figure 3. Folding Patterns of Phosducin in the center of the b propeller, making a tight interaction
Folding pattern of phosducin showing the arrangement of the sec- through an extensive hydrogen-bonding network as well
ondary structure elements. The folding pattern of phosducin is as van der Waals contacts. Helices 2 and 3 and their
shown on the left, with the “thioredoxin fold” (Martin, 1995) shaded adjoining loops make more peripheral contacts with the
gray. Thioredoxin’s folding pattern is shown on the right, with its
top of all seven Gtb blades.thioredoxin fold similarly shaded.
The residues of Gtb that contribute to the phosducin/
Gtbg interface are shown in Figure 7A. Although phos-et al., 1994; Fong et al., 1986). A coiled coil formed by
ducin has no internal symmetry of its own, there is a
the N-terminal helices of Gtb and Gtg packs against one degree of symmetry to the phosducin binding site on
side of the propeller, contacting blades 4 and 5. The
Gtbg. Three residues of the WD40 motif are repeatedlyC-terminus of Gtg packs against the bottom of the pro- involved in the N-terminal interface. These residues arepeller. Unlike the interaction of Gtbg with Gta which left the 16th, 18th, and 34th residues of the WD40 repeat,Gtbg essentially unaltered, Gtbg’s interaction with phos-
as numbered in Sondek et al. (1996) and shown sche-ducin leads to local conformational changes in three
matically in Figure 5C. The amino acid species at theseloops (highlighted in Figure 5B): residues 287–295, resi-
positions are not conserved from blade to blade, but aredues 308–318, and residues 329–338. These loops inter-
highly conserved across the spectrum of Gb sequences,act with helix 3 and the C-terminal domain of phosducin.
suggesting a canonical character to the interface. TheOtherwise, the RMSD between the a carbons of free
residue at position 34 of the WD40 repeat, projectingGtbg and those of phosducin-bound Gtbg is 1.5 A˚.
outward on the top propeller surface and contacting
phosducin in each of the seven repeats, is highly re-Phosducin/Gtbg Interface
strained stereochemically as it precedes the absolutelyThe two phosducin domains do not interact with each
conserved aspartate that is pointed inward to stabilizeother, instead they wrap around the side and the top of
the inner core of the Gtb blades. The 16th residue andthe Gtb propeller to form an extensive interaction surface
18th residue are close to the beginning of strand 1, aswith Gtbg (Figure6). The N-terminaldomain of phosducin
close to the propeller axis as a residue accessible frominteracts with all of the top loops of the b propeller
the top of the propeller can be. Residues at positionswhich, as noted above, is the same surface that interacts
16 and 18 contact phosducin in six of seven and fivewith Gta•GDP (Figure 7C). Thus phosducin’s N-terminal
out of seven repeats, respectively.domain interface in this complex clearly precludes asso-
The C-terminal domain binds to the “side” of the bciation of Gtbg with Gta. Phosducin’s C-terminal domain
propeller, as seen in Figure 6, where itwould not interferebinds to the side of the propeller opposite the coiled coil,
with Ga binding. This surface of Gbg has been impli-contacting blades 7 and 1, and is next to the C-terminal
cated in membrane binding and receptor interaction.prenylation site of Gtg, which anchors Gtbg to the mem-
This raises the possibility that, by disrupting the orienta-brane. The two interaction interfaces will be referred to
tion of Gbg relative to themembrane and receptor, phos-as the N-terminal interface and C-terminal interface.
ducin can interfere indirectly with the assembly and acti-Phosducin buries z2300 A˚2 of solvent-accessible sur-
vation of the Gabg heterotrimer. The C-terminal domainface area upon binding to Gtbg. The N-terminal domain
of phosducin, specifically strand 5 and its adjoiningof phosducin accounts for z1500 A˚2 and the C-terminal
domain buries z800 A˚2. The structure is consistent with loops as well as the C-terminal loop following helix 7,
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Figure 4. Structure of Phosducin
(A) Stereo pair showing the Ca trace of phosducin in the complex. The trace for residues 37 to 66 (open bars) is tentative. The N-terminal
domain is at the top and the C-terminal domain is at the bottom of the figure. Gtbg would be located to the right of the N-terminal domain.
The Ser-73 a carbon is enlarged and labeled. This figure was generated by DPLOT (G. Van Duyne).
(B) Stereo pair showing the least-squares superimposed Ca traces of the phosducin C-terminal domain (blue) and thioredoxin (Katti et al.,
1990) (red). The N- and C-terminal residues of the C-terminal domain are labeled P111 and P230, respectively. The N- and C-terminus of
thioredoxin are labeled T1 and T108. The C-terminal domain is viewed from its left side, relative to (A), in an orientation similar to that in
Figure 6A.
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Figure 5. Structural Changes in Gtbg
(A) Ribbons diagram (Carson and Bugg, 1986) of Gtbg colored to highlight each of the seven WD40 motifs. Strands and blades are labeled
according to the b-propeller convention, as in Sondek et al. (1996).
(B) Least-squares superposition of Ca atoms of free Gtbg (yellow) and Gtbg (green) in complex with phosducin. Highlighted loops 287–295,
308–318, and 329–338 (seen here from left to right) undergo conformational changes upon phosducin binding. The loops are blue in Gtbg
alone and magenta in Gtbg in complex with phosducin. Loop 127–135 of Gtb and the N-terminus of Gtb and Gtg also differ; however, the B
factors in these regions are high, and the differences in these cases are most likely due to crystal packing.
(C) Illustration of the consensus WD40 repeat, showing the relationship between consecutive repeats. The three residues repeatedly involved
in interactions with phosducin’s N-terminal domain are red. Strands from three consecutive blades are shown in black, blue, and gray. Residues
within one WD40 repeat are numbered following Sondek et al. (1996). Residues in white circles are pointing toward the viewer.
bind to the outer strands of blades 7 and 1 in Gtb. Two The phosducin footprint on Gtbg (2300 A˚2) is z700 A˚2
human phosducin sequence variants, N174K and larger than that of Gta, which buries z1600 A˚2 of Gtbg
G178R, are located in the loop between helix 5 and upon complex formation. The number of ionic and hy-
strand 4 and do not contact Gtbg. These variants were drophobic interactions in the phosducin/Gtbg complex
found in patients with retinopathies, although G178R is also proportionally larger. This correlates well with
was also found in normal subjects (Ara-Iwata et al., the observation that Gtbg interacts more strongly with
1996). If these variants are pathogenic in these retinopa- phosducin than with Gta. Published affinity constants
thies, it is not directly through a change in phosducin’s range from 17 nM to 110 nM for Gtbg/phosducin (Yosh-
interface with Gtbg. ida et al., 1994; Xu et al., 1995; Schro¨der and Lohse,
Except for three highly conservative variants, residues 1996) compared to z150 nM for the Gtbg/Gta•GDP inter-
in phosducin that contact Gb are identical in all known action (Mittal et al., 1994). It is noteworthy that neither
sequences (see Figure 1). This, coupled with the fact Gta nor phosducin contacts Gtg. The C-terminal domain
that all of the Gb residues contacting phosducin are of phosducin is closest to Gtg. At its closest point, the
themselves highly conserved, supports a conserved N-terminal end of helix 7, phosducin is still more than
stereochemistry for the phosducin/Gbg interface. Pres- 10 A˚ away from the C-terminus of Gtg. However, since
ervation of this regulatory phosducin/Gtbg interface the crystals were produced with Gtg that has been trun-
across species lines and throughout homologs within cated at its C-terminus, an interaction between the
each species is consistent with a general theme in het- C-terminus of Gtg and phosducin cannot be ruled out,
erotrimeric G-coupled signal transduction pathways; and it is not unlikely that the phosducin’s thioredoxin-
namely that the stereochemistry that regulates activity like domain interacts in some way with the farnesylated
is highly conserved. Thus a canonical mechanism is C-terminus of Gtg.likely to exist for downstream regulation functions as it
does for GTP-induced conformational change (Noel et
Effect of Phosducin Ser-73 Phosphorylational., 1993; Lambright et al., 1994), GTPase activity (Cole-
on Gtbg Interactionman et al., 1994; Sondek et al., 1994) and Ga–Gbg inter-
Willardson et al. (1996) recently proposed a completeactions (Wall et al., 1995; Lambright et al., 1996). This
phosducin phosphorylation/dephosphorylation cycle inconserved interface also explains why phosducin has a
retinal rods that explains how PKA mediates light-similar affinity for all Gbg dimers tested (Mu¨ller et al.,
dependent phosducin phosphorylation. Upon light-1996) and suggests that it might be a general regulator
in a variety of tissues. adaptation, a decrease in the cGMP concentration leads
Cell
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Figure 6. Ribbon Representation of the Phosducin/Gtbg Complex
Phosducin’s N-terminal domain is purple, the C-terminal domain is blue, Gtb is gold, and Gtg is silver. The poorly defined segment from 37
to 66 in phosducin is green. Phosducin’s Ser-73 residue is depicted in a ball-and-stick representation, with the side chain oxygen shown in
red. (A) Facing the top of the b propeller, similar to Figure 5. (B) Side view of the complex, looking approximately from the bottom right corner
of (A). This view of phosducin is similar to that in Figure 4A except that it is rotated clockwise z908 in the plane of the paper.
to the closure of cGMP-gated cation channels and the as seen in Figure 7C. Lambright et al. (1996) proposed
that the remainder of this positively charged surfaceintracellular Ca21 concentration falls. In response to
lower Ca21 levels, adenylyl cyclase activity decreases, interacts with the membrane surface, as this would
properly orient the Gta region implicated in receptorreducing the cAMP concentration. This deactivates
PKA, increasing the concentration of unphosphorylated, binding for interaction with rhodopsin. Figure 8 shows
that the thioredoxin-like domain of phosducin binds thisactive phosducin. Upon dark-adaptation, the levels of
cGMP and cAMP increase, and the phosducin phos- region of Gtbg, thereby sterically blocking the proposed
Gtbg interaction with the membrane. Furthermore, thephorylation level returns to the elevated state, maximiz-
ing signal amplification. C-terminal domain of phosducin is highly negatively
charged, as illustrated by the large heart-shaped nega-As seen in Figure 6, the side chain of Ser-73, phosduc-
in’s PKA phosphorylation site, points toward the 30- tive electrostatic potential surrounding the thioredoxin-
like domain in Figure 8. This negative electrostatic po-residue disordered segment of phosducin, not toward
Gtbg. Furthermore, Ser-73 is on the surface of phos- tential could play one or both of two roles: it could mimic
the negative electrostatic potential of the membrane toducin, accessible to PKA even in the phosducin/Gtbg
complex, as has been shown biochemically (Wilkins et enable phosducin to compete favorably with the mem-
brane for binding to Gtbg, and/or it could create electro-al., 1996). Therefore, phosphorylation of Ser-73 does
not lead directly to disruption of phosducin/Gtbg interac- static repulsion to push Gtbg away from the negatively
charged membrane surface. All of the proposed stereo-tions. Instead, the structure suggests that phosphoryla-
tion might lead to conformational changes in phosduc- chemical and electrostatic effects lead to phosducin
translocating Gtbg away from the membrane, into thein’s N-terminal domain, especially in the flexible but
highly conserved segment from 37 to 66, that could cytosol, where the phosducin/Gtbg complex is normally
found (Lee et al., 1988). Consistent with this view is theweaken or alter the phosducin/Gtbg interface. A number
of phosducin’s positively charged residues, notably Lys- fact that phosducin’s low isoelectric point (predicted
pI 5 4.4) results from a very uneven distribution of nega-23, Arg-30 and Lys-71, are in close proximity to the
phosphorylation site and could mediate a conforma- tive residues, presumably for functional reasons: the
N-terminal domain of phosducin (residues 1–110) has ational change within the N-terminaldomain of phosducin
upon phosphorylation. net charge of 23 whereas the C-terminal domain (111–
246) has a net charge of 219.
Electrostatic Potential of the Complex
and Gtbg Translocation Functional Implications
Two types of heterotrimeric G protein regulators haveFigure 8 illustrates theelectrostatic potential of free Gtbg
and of the phosducin/Gtbg complex. Gtbg has a posi- been identified. RGS (regulator of G protein signaling
similarity) domain proteins act on Ga subunits, increas-tively charged surface on the side of the propeller where
the farnesylated C-terminus of Gtg is located. The myris- ing their rate of GTP hydrolysis (Berman et al., 1996).
Phosducin also down-regulates G protein function, intoylated N-terminus of Gta binds to the right side of this
region, contacting the outer strands of blades 1 and 2, this case by acting on Gbg subunits, binding Gbg, and
Structure of the Phosducin/Transducin bg Complex
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Figure 7. Phosducin/Gtbg Interactions
(A) Ribbon diagram showing the position of the Gtbg residues that interact with phosducin. Gtb is gold; Gtg is silver. Corresponding phosducin-
interacting residues are color-coded green for van der Waals interactions and red for ionic interactions and hydrogen bonds. The numbers
16, 18, and 34 placed directly on the ribbons correspond to positions in a WD40 repeat structure as numbered in Figure 5C. The orientation
is the same as in Figure 5.
(B) Diagram showing the position of the phosducin residues interacting with Gtbg. Residues that contact Gtbg are yellow. The orientation is
the same as in Figure 6B.
(C) Molecular surface representation of Gtbg in the same orientation as in (A) showing the surfaces that interact with phosducin (blue), Gta
(red), or both phosducin and Gta (purple). Gtb is yellow and Gtg is white.
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Figure 8. Electrostatic Potential Representation of Phosducin/Gtbg and Gtbg Alone
Electrostatic potential contoured at 11.5 kT (blue) and 21.5 kT (red) (ionic strength 5 100 mM). On the left is the phosducin/Gtbg complex,
in the same orientation as in Figure 6A. On the right is Gtbg alone, in the same orientation. This figure was generated using GRASP (Nicholls
and Honig, 1991).
translocating Gbg from the membrane to the cytosol, Gbg is now seen as an active component of the signal
transduction system, interacting with numerous ef-thus preventing heterotrimer reassociation and subse-
quent rounds of receptor-mediatedG protein activation. fectors. Gbg subunits have been implicated as activa-
tors or inhibitors of various effectors (reviewed in Clap-Phosducin’s two domains are both spatially and func-
tionally separate. Whereas the N-terminal domain is re- ham and Neer, 1993), including phospholipase C, inward
rectifier potassium channels and certain isoforms of ad-sponsible for competing with Gta for the top face of
Gtbg, the C-terminal domain appears to be responsible enylyl cyclase. Gbg subunits are also responsible for
localizing b-adrenergic receptor kinase (Pitcher et al.,for Gtbg translocation away from the membrane. If the
two phosducin domains are independently stable and 1992) and Raf1 kinase (Pumiglia et al., 1995) to the cell
membrane, thereby targeting these kinases to theircan perform each of these roles on their own, they would
be powerful tools to study various aspects of Gtbg inter- membrane-bound substrates. As phosducin is present
in various tissues and binds Gtbg through conserved Gbactions with effectors and Gta. Some experiments along
these lines have already been done. Xu et al. (1995) and residues, phosducin is likely to be an important modula-
tor of Gbg function not only in the visual system, butHawes et al. (1994) showed that in transfection experi-
ments the N-terminal regions of phosducin can inhibit also in other signal transduction pathways as well. In
the visual system, Gtbg is not thought to interact withdownstream effectors. Furthermore, Tanaka et al. (1996)
showed that, while the N-terminal domain binds Gtbg, proteins other than Gta and phosducin. However in other
systems, Gbg binds other proteins as well, opening upbinding does not lead to Gtbg’s membrane dissociation.
With regard to the C-terminal domain, it should be noted the possibility that phosducin, through a common bind-
ing mechanism, has different modulating functions spe-that PhlP binds Gbg subunits even though it lacks most
of the N-terminal domain (Schro¨der and Lohse, 1996). cific to the various pathways.
However, Tanaka et al. (1996) have indicated that phos-
ducin’s C-terminal domain was not sufficient for mem-
Experimental Procedures
brane dissociation of Gtbg, and it is possible that the
binding surface area in the absence of at least part of Purification of Gtbg
the N-terminal domain is simply too small to support a Gtbg was purified from bovine rod outer segments (ROS) using ex-
isting protocols (Bigay and Chabre, 1994). ROS membranes werestable interaction.
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exposed to light, washed, then Gt was released with GTPgS. Gt was and a fifth dataset was collected at l4, at the gadolinium Df99 maxi-
mum. The data were reduced and scaled using DENZO and SCALE-digested with endoproteinase LysC (endo-LysC), incubating 40 mg
of Gt with 20 U of endo-LysC for 48 hr at 48C. Endo-LysC cleaves PACK (Z. Otwinoski). Three Gd31 sites were identified in the l4 anom-
alous difference Patterson, using the program SHELXS (Sheldrick,Gtg after Lys-68, removing the last three residues as well as the
farnesyl moiety at Cys-71. Gta and Gtbg were then separated on a 1990). Two more Gd31 sites were found in the l4 anomalous differ-
ence Fourier maps calculated using the preliminary MAD phases.Cibacron Blue 3GA-Agarose column (Sigma). Gtbg was further puri-
fied on a Mono-Q column (Pharmacia) eluting with an NaCl gradient, Four Se sites were also found in the l3 anomalous difference Fourier
maps. The anomalous and isomorphous occupancies at l2, l3 andconcentrated and buffer-exchanged using a Centricon-10 (Amicon)
to a final concentration of >90 mg/ml. The protein was stored frozen l4 were refined against the l1 dataset (in which the Friedel pairs
were merged) using MLPHARE (Z. Otwinoski, modified by G. Vanat 2808C in 5 mM Tris–HCl (pH 7.5), 5 mM MgCl2, 15 mM NaCl, and
40% glycerol. Duyne). Table 2 summarizes phasing statistics. It was not necessary
to use the phases derived from the Gtbg model (Sondek et al., 1996),
which had been correctly positioned by molecular replacement, to
Expression and Purification of Phosducin
find the anomalous scatterers. Solvent flattening and partial model-
The full-length open reading frame of the rat phosducin cDNA (ATCC
combination were done with the program DPHASE (G. Van Duyne).
63147; Craft et al., 1991) was subcloned into the pET15b (Novagen)
The bulk of phosducin was then traced using the solvent-flattened
NdeI and BamHI sites using PCR with the following primer se-
MAD experimental map, using the program O (Jones et al., 1991),
quences: 59-CGCGGCAGCC ATATGGAAGA AGCCGCAAGC C-39
and the model was completed using both experimental maps and
and 59-AGCCGGATCC TTATTACTTC GATATCTTCA TCTTCC-39.
partial model combined maps. The model was refined against a
N-terminally His-tagged phosducin was expressed in the methionine combined dataset in which both the l1 and the l1–2 datasets wereauxotrophic E. coli strain B834 (DE3) (Novagen) in a MOPS-based merged, using data from 50 to 2.4 A˚, with a flat bulk solvent correc-
minimal media (Neidhardt et al., 1974) containing 50 mg/l DL-seleno- tion (Jiang and Bru¨nger, 1994). Table 3 shows the refinement statis-
methionine (Sigma) instead of methionine. Cells were grown at 378C.
tics. The molecular replacement and model refinement were carried
The expression of phosducin was induced with 0.4 mM IPTG at an
out with XPLOR 3.8 (Bru¨nger, 1992). Packing and solvent accessibil-
optical density of 0.8 (600 nm), and the cells were harvested 3 hr
ity analysis was done using DSSP (Kabsch and Sander, 1983).
after induction. Cells were lysed by sonication in 20 mM Tris–HCl
(pH 8), 500 mM NaCl, 1 mM PMSF, 0.1% Triton, 0.05% b-mercapto-
ethanol (b-ME) and the lysate centrifuged at 120,0003 g. The soluble Acknowledgments
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